Allogene Therapeutics ALLO
NASDAQ ALLO
$0.90 -0.03 (-3.41%)
At close: Nov 11, 2026 · 4:00 PM EST

Allogene Therapeutics (ALLO) Asset Writedowns and Impairment (2022 - 2025)

Updated

Allogene Therapeutics (ALLO) reported Asset Writedowns and Impairment of $18,000 for Q4 2025.

Analysis

Allogene Therapeutics (ALLO) Asset Writedowns and Impairment (2022 - 2025) Analysis & Trends

For FY2025, Allogene Therapeutics posted Asset Writedowns and Impairment of $2.4 million, down 84.7% from FY2024.

  • By year, Asset Writedowns and Impairment came in at $15.72 million in FY2024 (+18.7%) and $13.25 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Allogene Therapeutics 322.04 Mn -820.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 18,000.00
Jun 30, 2025 2.38 Mn
Sep 30, 2024 10.73 Mn
Jun 30, 2024 4.99 Mn
Dec 31, 2023 10.25 Mn
Dec 31, 2022 -3.96 Mn
API Access

Allogene Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ALLO&period=max&api_key=YOUR_API_KEY